JP2007530570A5 - - Google Patents

Download PDF

Info

Publication number
JP2007530570A5
JP2007530570A5 JP2007505143A JP2007505143A JP2007530570A5 JP 2007530570 A5 JP2007530570 A5 JP 2007530570A5 JP 2007505143 A JP2007505143 A JP 2007505143A JP 2007505143 A JP2007505143 A JP 2007505143A JP 2007530570 A5 JP2007530570 A5 JP 2007530570A5
Authority
JP
Japan
Prior art keywords
methyl
imidazol
phenyl
compounds
effective amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007505143A
Other languages
English (en)
Japanese (ja)
Other versions
JP5162236B2 (ja
JP2007530570A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/009715 external-priority patent/WO2005092066A2/en
Publication of JP2007530570A publication Critical patent/JP2007530570A/ja
Publication of JP2007530570A5 publication Critical patent/JP2007530570A5/ja
Application granted granted Critical
Publication of JP5162236B2 publication Critical patent/JP5162236B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007505143A 2004-03-25 2005-03-24 イミダゾール化合物 Expired - Fee Related JP5162236B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55635604P 2004-03-25 2004-03-25
US60/556,356 2004-03-25
PCT/US2005/009715 WO2005092066A2 (en) 2004-03-25 2005-03-24 Imidazole compounds

Publications (3)

Publication Number Publication Date
JP2007530570A JP2007530570A (ja) 2007-11-01
JP2007530570A5 true JP2007530570A5 (cg-RX-API-DMAC7.html) 2008-04-24
JP5162236B2 JP5162236B2 (ja) 2013-03-13

Family

ID=35056771

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007505143A Expired - Fee Related JP5162236B2 (ja) 2004-03-25 2005-03-24 イミダゾール化合物

Country Status (18)

Country Link
US (9) US7253200B2 (cg-RX-API-DMAC7.html)
EP (1) EP1737297B1 (cg-RX-API-DMAC7.html)
JP (1) JP5162236B2 (cg-RX-API-DMAC7.html)
KR (1) KR101217103B1 (cg-RX-API-DMAC7.html)
CN (1) CN101022728B (cg-RX-API-DMAC7.html)
AU (1) AU2005226729B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0509164A (cg-RX-API-DMAC7.html)
CA (1) CA2560896C (cg-RX-API-DMAC7.html)
CR (1) CR8704A (cg-RX-API-DMAC7.html)
EA (1) EA011242B1 (cg-RX-API-DMAC7.html)
EC (1) ECSP066882A (cg-RX-API-DMAC7.html)
IL (2) IL178287A (cg-RX-API-DMAC7.html)
MX (1) MXPA06011021A (cg-RX-API-DMAC7.html)
NO (1) NO20064848L (cg-RX-API-DMAC7.html)
NZ (1) NZ550087A (cg-RX-API-DMAC7.html)
UA (1) UA89226C2 (cg-RX-API-DMAC7.html)
WO (1) WO2005092066A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200608836B (cg-RX-API-DMAC7.html)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5162236B2 (ja) * 2004-03-25 2013-03-13 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ イミダゾール化合物
GB0525068D0 (en) 2005-12-08 2006-01-18 Novartis Ag Organic compounds
AU2007235577B2 (en) * 2006-03-31 2011-09-15 Janssen Pharmaceutica N.V. Benzoimidazol-2-yl pyridines as modulators of the histamine H4 receptor
ATE478067T1 (de) * 2006-03-31 2010-09-15 Janssen Pharmaceutica Nv Benzoimidazol-2-yl pyridine und pyrazine als modulatoren des histamin-h4-rezeptors
WO2007120690A2 (en) * 2006-04-10 2007-10-25 Janssen Pharmaceutica N.V. Combination histamine h1r and h4r antagonist therapy for treating pruritus
ES2441958T3 (es) * 2006-07-11 2014-02-07 Janssen Pharmaceutica Nv Moduladores de benzofuro- y benzotienopirimidina del receptor de histamina H4
US7985745B2 (en) 2006-10-02 2011-07-26 Abbott Laboratories Method for pain treatment
CL2008000467A1 (es) * 2007-02-14 2008-08-22 Janssen Pharmaceutica Nv Compuestos derivados de 2-aminopirimidina, moduladores del receptor histamina h4; su procedimiento de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar un trastorno inflamatorio seleccionado de alegia, asma
TW200924781A (en) 2007-09-14 2009-06-16 Janssen Pharmaceutica Nv Thieno- and furo-pyrimidine modulators of the histamine H4 receptor
US8084466B2 (en) * 2007-12-18 2011-12-27 Janssen Pharmaceutica Nv Bicyclic heteroaryl-substituted imidazoles as modulators of the histamine H4 receptor
UA100567C2 (ru) * 2008-06-12 2013-01-10 Янссен Фармацевтика Нв Использование антагонистов н4-гистаминовых рецепторов для лечения послеоперационных спаек
EA020090B1 (ru) * 2008-06-30 2014-08-29 Янссен Фармацевтика Нв Способ получения и рекристаллизации кристаллического гемитартрата бензоимидазол-2-илпиримидинового производного
US9371311B2 (en) 2008-06-30 2016-06-21 Janssen Pharmaceutica Nv Benzoimidazol-2-yl pyrimidine derivatives
US9145396B2 (en) 2008-12-01 2015-09-29 Targacept, Inc. Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3ylvinyl)pyrimidine
IL266097B (en) * 2008-12-01 2022-07-01 Oyster Point Pharma Inc Mono-orotate acid addition salt of r(–5–)–e(–2–)pyrrolidine––3ylvinyl)pyrimidine
EP2201982A1 (en) 2008-12-24 2010-06-30 INSERM (Institut National de la Santé et de la Recherche Médicale) Histamine H4 receptor antagonists for the treatment of vestibular disorders
US8349852B2 (en) 2009-01-13 2013-01-08 Novartis Ag Quinazolinone derivatives useful as vanilloid antagonists
RS55607B1 (sr) 2009-08-20 2017-06-30 Yeda Research & Development Company Ltd Niskofrekventna terapija glatiramer acetatom
USRE49251E1 (en) 2010-01-04 2022-10-18 Mapi Pharma Ltd. Depot systems comprising glatiramer or pharmacologically acceptable salt thereof
CN102762572A (zh) 2010-02-01 2012-10-31 诺瓦提斯公司 作为CRF-1受体拮抗剂的吡唑并[5,1b]*唑衍生物
AR080056A1 (es) 2010-02-01 2012-03-07 Novartis Ag Derivados de ciclohexil-amida como antagonistas de los receptores de crf
EP2531490B1 (en) 2010-02-02 2014-10-15 Novartis AG Cyclohexyl amide derivatives as crf receptor antagonists
UY34094A (es) 2011-05-27 2013-01-03 Novartis Ag Derivados de la piperidina 3-espirocíclica como agonistas de receptores de la ghrelina
WO2013164790A1 (en) 2012-05-03 2013-11-07 Novartis Ag L-malate salt of 2, 7 - diaza - spiro [4.5 ] dec- 7 - yle derivatives and crystalline forms thereof as ghrelin receptor agonists
HUE039713T2 (hu) 2012-06-08 2019-02-28 Sensorion H4 receptor inhibitorok tinnitus kezelésére
JO3516B1 (ar) 2013-03-06 2020-07-05 Janssen Pharmaceutica Nv مُعدِّلات بنزإيميدازول-2-يل بيريميدين لمستقبل الهستامين h4
US10414766B2 (en) * 2015-12-15 2019-09-17 Alembic Pharmaceuticals Limited Polymorph of Riociguat and its process for the preparation
US12097292B2 (en) 2016-08-28 2024-09-24 Mapi Pharma Ltd. Process for preparing microparticles containing glatiramer acetate
AU2017319728B2 (en) 2016-08-31 2024-09-05 Mapi Pharma Ltd Depot systems comprising glatiramer acetate
IL316573A (en) 2017-03-26 2024-12-01 Mapi Pharma Ltd Storage systems containing glatiramer acetate for the treatment of multiple sclerosis

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4187213A (en) * 1978-01-09 1980-02-05 Eastman Kodak Company Multiheterocyclic ultraviolet stabilizers and their use in organic compositions
FR2665161B1 (fr) * 1990-07-26 1992-11-27 Esteve Labor Dr Nouveaux derives de benzimidazole, leur preparation et leur application en tant que medicaments.
JP2002505690A (ja) * 1997-06-19 2002-02-19 スミスクライン・ビーチャム・コーポレイション 新規なアリールオキシピリミジン置換イミダゾール化合物
TR200101239T2 (tr) * 1998-11-03 2001-11-21 Basf Aktiengesellschaft İkameli-2-fenilbenzimidazoller, üretimleri ve kullanımları
CZ2003686A3 (cs) * 2000-08-08 2003-08-13 Ortho Mcneil Pharmaceutical, Inc. Neimidazolové aryloxypiperidiny
AU2003256297A1 (en) * 2002-08-09 2004-02-25 Eli Lilly And Company Benzimidazoles and benzothiazoles as inhibitors of map kinase
SE0202462D0 (sv) * 2002-08-14 2002-08-14 Astrazeneca Ab Novel use
PL378919A1 (pl) * 2003-04-10 2006-06-12 Avanir Pharmaceuticals Pochodne imidazolu do leczenia zaburzeń alergicznych i nadmiernego rozrostu
AR045955A1 (es) * 2003-09-30 2005-11-16 Janssen Pharmaceutica Nv Compuestos benzoimidazolicos
JP5162236B2 (ja) * 2004-03-25 2013-03-13 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ イミダゾール化合物

Similar Documents

Publication Publication Date Title
CA1255663A (en) 5-pyridyl-1,3-thiazole derivatives, their production and use
RU2006110561A (ru) Соединения бензоимидазола
JP4173738B2 (ja) Erk2の複素環式インヒビターおよびその使用
JP2013531055A5 (cg-RX-API-DMAC7.html)
US8440708B2 (en) Triazole-substituted arylamides as P2X3 and P2X2/3 antagonists
AU2005226729B2 (en) Imidazole compounds
JP2010513272A5 (cg-RX-API-DMAC7.html)
US20100240618A1 (en) Substituted piperazines
JP2008501698A (ja) 代謝の調節因子としての置換アリールおよびヘテロアリール誘導体ならびにそれらに関連する疾患の予防および処置
JP2013517283A5 (cg-RX-API-DMAC7.html)
JP2008516974A5 (cg-RX-API-DMAC7.html)
JP2004521908A5 (cg-RX-API-DMAC7.html)
JP2009536197A5 (cg-RX-API-DMAC7.html)
JP2019537594A5 (cg-RX-API-DMAC7.html)
US9173861B2 (en) Thiadiazole-substituted arylamides as P2X3 and P2X2/3 antagonists
RU2007124935A (ru) АМИНОПИРИДИНЫ В КАЧЕСТВЕ ИНГИБИТОРОВ β-СЕКТРЕТАЗЫ
JP2006522820A5 (cg-RX-API-DMAC7.html)
JP2006526596A5 (cg-RX-API-DMAC7.html)
JP2013535414A5 (cg-RX-API-DMAC7.html)
HRP20151110T1 (hr) Derivat 5-hidroksipirimidin-4-karboksamida
RU2011141794A (ru) Амидное производное
RU2382028C2 (ru) Производные амидов, несущие циклопропиламинокарбонильный заместитель, пригодные в качестве ингибиторов цитокинов
JP5391269B2 (ja) ピペラジン化合物、それを含む医薬組成物
RU2149872C1 (ru) Пиридилтиосоединения для борьбы с бактериями helicobacter
JP2007533707A5 (cg-RX-API-DMAC7.html)